VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients

Leukocyte differentiation antigens often represent important markers for the diagnosis, classification, prognosis, and therapeutic targeting of myeloid leukemia. Herein, we report a potential leukocyte differentiation antigen gene VSTM1 (V-set and transmembrane domain-containing 1) that was downregu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Min, Li, Ting, Li, Ning, Li, Jinlan, Yao, Qiumei, Han, Wenling, Ruan, Guorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405901/
https://www.ncbi.nlm.nih.gov/pubmed/25887911
http://dx.doi.org/10.1186/s13045-015-0118-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405901/
https://www.ncbi.nlm.nih.gov/pubmed/25887911
http://dx.doi.org/10.1186/s13045-015-0118-4

Ejemplares similares